ERBB2, TBX2, RPS6KB1, and MYC alterations in breast tissues of BRCA1 and BRCA2 mutation carriers
暂无分享,去创建一个
Daniel J Schaid | Fergus Couch | Jeffrey M Slezak | Thomas A Sellers | Carol Reynolds | T. Sellers | D. Schaid | F. Couch | L. Hartmann | C. Reynolds | Robert B Jenkins | J. Slezak | Lynn C Hartmann | Camilo Adem | Cheryl L Soderberg | Kari Hafner | Colleen S Sinclair | Colleen S. Sinclair | C. Sinclair | C. Adem | C. L. Soderberg | Robert B. Jenkins | Kari A. Hafner | Cheryl L. Soderberg
[1] P. Chappuis,et al. Clinico-pathological characteristics of BRCA1- and BRCA2-related breast cancer. , 2000, Seminars in surgical oncology.
[2] S. Cummings,et al. Sequence analysis of BRCA1 and BRCA2: correlation of mutations with family history and ovarian cancer risk. , 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[3] G E Tomlinson,et al. BRCA2 is required for ionizing radiation-induced assembly of Rad51 complex in vivo. , 1999, Cancer research.
[4] J. Sudbø,et al. Gene-expression profiles in hereditary breast cancer. , 2001, The New England journal of medicine.
[5] M. Schwab,et al. Constitutional genomic instability with inversions, duplications, and amplifications in 9p23-24 in BRCA2 mutation carriers. , 2001, Cancer research.
[6] O. Kallioniemi,et al. Somatic genetic alterations in BRCA2‐associated and sporadic male breast cancer , 1999, Genes, chromosomes & cancer.
[7] X. Wang,et al. Centrosome amplification and a defective G2-M cell cycle checkpoint induce genetic instability in BRCA1 exon 11 isoform-deficient cells. , 1999, Molecular cell.
[8] K. Kinzler,et al. Genetic instabilities in human cancers , 1998, Nature.
[9] P. O’Connell,et al. Analysis of loss of heterozygosity in 399 premalignant breast lesions at 15 genetic loci. , 1998, Journal of the National Cancer Institute.
[10] Persons Dl,et al. Quantitation of HER-2/neu and c-myc gene amplification in breast carcinoma using fluorescence in situ hybridization , 1997 .
[11] S. Elledge,et al. BASC, a super complex of BRCA1-associated proteins involved in the recognition and repair of aberrant DNA structures. , 2000, Genes & development.
[12] Michael D Feldman,et al. Molecular-cytogenetic analysis of HER-2/neu gene in BRCA1-associated breast cancers. , 2002, Cancer research.
[13] P. Chappuis,et al. TP53 mutations in breast cancer associated with BRCA1 or BRCA2 germ-line mutations: distinctive spectrum and structural distribution. , 2001, Cancer research.
[14] J Isola,et al. Distinct somatic genetic changes associated with tumor progression in carriers of BRCA1 and BRCA2 germ-line mutations. , 1997, Cancer research.
[15] H. Kiyosawa,et al. Analysis of the CMT1A-REP repeat: mapping crossover breakpoints in CMT1A and HNPP. , 1995, Human molecular genetics.
[16] James N Ingle,et al. HER2 testing in patients with breast cancer: poor correlation between weak positivity by immunohistochemistry and gene amplification by fluorescence in situ hybridization. , 2002, Mayo Clinic proceedings.
[17] Thea D. Tlsty,et al. Normal human mammary epithelial cells spontaneously escape senescence and acquire genomic changes , 2001, Nature.
[18] Daniel J Schaid,et al. Pathologic characteristics of breast parenchyma in patients with hereditary breast carcinoma, including BRCA1 and BRCA2 mutation carriers , 2003, Cancer.
[19] M. Jasin,et al. Homology-directed dna repair, mitomycin-c resistance, and chromosome stability is restored with correction of a Brca1 mutation. , 2001, Cancer research.
[20] L. Cupples,et al. Genetically abnormal clones in histologically normal breast tissue. , 1998, The American journal of pathology.
[21] Dieter Niederacher,et al. Multistep carcinogenesis of breast cancer and tumour heterogeneity , 1997, Journal of Molecular Medicine.
[22] E. Prochownik,et al. C-myc overexpression and p53 loss cooperate to promote genomic instability , 1999, Oncogene.
[23] B. Trock,et al. C-myc amplification in breast cancer: a meta-analysis of its occurrence and prognostic relevance , 2000, British Journal of Cancer.
[24] B. Dutrillaux,et al. Induction of multiple double-strand breaks within an hsr by meganucleaseI-SceI expression or fragile site activation leads to formation of double minutes and other chromosomal rearrangements , 2002, Oncogene.
[25] M. J. van de Vijver,et al. The pathology of familial breast cancer: predictive value of immunohistochemical markers estrogen receptor, progesterone receptor, HER-2, and p53 in patients with mutations in BRCA1 and BRCA2. , 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[26] Hans Joenje,et al. Biallelic Inactivation of BRCA2 in Fanconi Anemia , 2002, Science.
[27] Marcel J T Reinders,et al. Molecular classification of breast carcinomas by comparative genomic hybridization: a specific somatic genetic profile for BRCA1 tumors. , 2002, Cancer research.
[28] A. Ashworth,et al. Absence of Brca2 causes genome instability by chromosome breakage and loss associated with centrosome amplification , 1999, Current Biology.
[29] D J Schaid,et al. Efficacy of bilateral prophylactic mastectomy in women with a family history of breast cancer. , 1999, The New England journal of medicine.
[30] J. Isola,et al. Chromosomal rearrangements and oncogene amplification precede aneuploidization in the genetic evolution of breast cancer. , 2001, Cancer research.
[31] G. Wahl,et al. c-Myc can induce DNA damage, increase reactive oxygen species, and mitigate p53 function: a mechanism for oncogene-induced genetic instability. , 2002, Molecular cell.
[32] J. Isola,et al. Amplification of c-myc by Fluorescence In Situ Hybridization in a Population-Based Breast Cancer Tissue Array , 2001, Modern Pathology.
[33] Fergus J Couch,et al. TBX2 is preferentially amplified in BRCA1- and BRCA2-related breast tumors. , 2002, Cancer research.
[34] G. Casey,et al. Absence of CCND1 gene amplification in breast tumours of BRCA1 mutation carriers , 2001, Molecular pathology : MP.
[35] Hui Tian,et al. BRCA1 physically associates with p53 and stimulates its transcriptional activity , 1998, Oncogene.
[36] P. Meraldi,et al. Aurora‐A overexpression reveals tetraploidization as a major route to centrosome amplification in p53−/− cells , 2002, The EMBO journal.
[37] T. Sellers,et al. Efficacy of contralateral prophylactic mastectomy in women with a personal and family history of breast cancer. , 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[38] S. Elledge,et al. Requirement of ATM-dependent phosphorylation of brca1 in the DNA damage response to double-strand breaks. , 1999, Science.
[39] D. Persons,et al. Quantitation of HER-2/neu and c-myc gene amplification in breast carcinoma using fluorescence in situ hybridization. , 1997, Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc.